|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2006-11-27
|
|
pubmed:abstractText |
The authors investigated how lymphopenia and low serum albumin levels correlate with the prognosis of patients with carcinoma of unknown primary (CUP).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2006 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
107
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2698-705
|
|
pubmed:dateRevised |
2007-7-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17063500-Adult,
pubmed-meshheading:17063500-Aged,
pubmed-meshheading:17063500-Aged, 80 and over,
pubmed-meshheading:17063500-Female,
pubmed-meshheading:17063500-Humans,
pubmed-meshheading:17063500-L-Lactate Dehydrogenase,
pubmed-meshheading:17063500-Liver Neoplasms,
pubmed-meshheading:17063500-Male,
pubmed-meshheading:17063500-Middle Aged,
pubmed-meshheading:17063500-Multivariate Analysis,
pubmed-meshheading:17063500-Neoplasms, Unknown Primary,
pubmed-meshheading:17063500-Prognosis,
pubmed-meshheading:17063500-Serum Albumin,
pubmed-meshheading:17063500-Survival Rate,
pubmed-meshheading:17063500-Tumor Markers, Biological
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site.
|
|
pubmed:affiliation |
Department of Internal Medicine, Hotel Dieu, Hospices Civils de Lyon, Lyon, France. pascal.seve@chu-lyon.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
